Evidence map›Paper›PMID 36523270›Full record

ArticleBrain communications2022

Interictal epileptiform discharges as a predictive biomarker for recurrence of poststroke epilepsy.

Soichiro Abe, Tomotaka Tanaka, Kazuki Fukuma, Soichiro Matsubara, Rie Motoyama, Masahiro Mizobuchi, Hajime Yoshimura, Takayuki Matsuki, Yasuhiro Manabe, Junichiro Suzuki and 13 more

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 1 country.

Soichiro AbeDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 5648565, Japan.ORCID https://orcid.org/0000-0001-9528-8702
Tomotaka TanakaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 5648565, Japan.ORCID https://orcid.org/0000-0002-6023-236X
Kazuki FukumaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 5648565, Japan.ORCID https://orcid.org/0000-0001-8117-8916
Soichiro MatsubaraDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 8608556, Japan.ORCID https://orcid.org/0000-0002-7905-1067
Rie MotoyamaDepartment of Neurology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo 1730015, Japan.ORCID https://orcid.org/0000-0003-3632-2477
Masahiro MizobuchiDepartment of Neurology, Nakamura Memorial Hospital, Sapporo 0608570, Japan.
Hajime YoshimuraDepartment of Neurology, Kobe City Medical Center General Hospital, Kobe 6500047, Japan.ORCID https://orcid.org/0000-0002-3523-366X
Takayuki MatsukiDepartment of Neurology, St Mary's Hospital, Fukuoka 8300047, Japan.
Yasuhiro ManabeDepartment of Neurology, National Hospital Organization Okayama Medical Center, Okayama 7011192, Japan.
Junichiro SuzukiDepartment of Neurology, Toyota Memorial Hospital, Toyota 4718513, Japan.ORCID https://orcid.org/0000-0002-5465-7169
Hiroyuki IshiyamaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 5648565, Japan.ORCID https://orcid.org/0000-0003-0071-7338
Maya TojimaDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto 6068507, Japan.ORCID https://orcid.org/0000-0002-2715-1410
Katsuya KobayashiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto 6068507, Japan.ORCID https://orcid.org/0000-0002-5492-1660
Akihiro ShimotakeDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto 6068507, Japan.ORCID https://orcid.org/0000-0003-3777-685X
Kunihiro NishimuraDepartment of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Osaka 5648565, Japan.
Masatoshi KogaDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka 5648565, Japan.
Kazunori ToyodaDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka 5648565, Japan.ORCID https://orcid.org/0000-0002-8346-9845
Shigeo MurayamaDepartment of Neurology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo 1730015, Japan.ORCID https://orcid.org/0000-0001-9709-5242
Riki MatsumotoDivision of Neurology, Kobe University Graduate School of Medicine, Kobe 6500017, Japan.ORCID https://orcid.org/0000-0003-3985-9210
Ryosuke TakahashiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto 6068507, Japan.ORCID https://orcid.org/0000-0002-1407-9640
Akio IkedaDepartment of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Kyoto 6068507, Japan.ORCID https://orcid.org/0000-0003-2374-3002
Masafumi IharaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 5648565, Japan.ORCID https://orcid.org/0000-0002-7102-4048
PROPOSE Study Investigators
National Cerebral and Cardiovascular Center · JPKyoto University · JPTokyo Metropolitan Geriatric Hospital · JPKobe City Medical Center General Hospital · JPKobe University · JPKumamoto University · JPNational Hospital Organization · JPSapporo Minami Hospital · JPSt Mary's Hospital · JPToyota Memorial Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poststroke epilepsy is a major ischaemic/haemorrhagic stroke complication. Seizure recurrence risk estimation and early therapeutic intervention are critical, given the association of poststroke epilepsy with worse functional outcomes, quality of life and greater mortality. Several studies have reported risk factors for seizure recurrence; however, in poststroke epilepsy, the role of EEG in predicting the risk of seizures remains unclear. This multicentre observational study aimed to clarify whether EEG findings constitute a risk factor for seizure recurrence in patients with poststroke epilepsy. Patients with poststroke epilepsy were recruited from the PROgnosis of POst-Stroke Epilepsy study, an observational multicentre cohort study. The enrolled patients with poststroke epilepsy were those admitted at selected hospitals between November 2014 and June 2017. All patients underwent EEG during the interictal period during admission to each hospital and were monitored for seizure recurrence over 1 year. Board-certified neurologists or epileptologists evaluated all EEG findings. We investigated the relationship between EEG findings and seizure recurrence. Among 187 patients with poststroke epilepsy (65 were women with a median age of 75 years) admitted to the lead hospital, 48 (25.7%) had interictal epileptiform discharges on EEG. During the follow-up period (median, 397 days; interquartile range, 337-450 days), interictal epileptiform discharges were positively correlated with seizure recurrence (hazard ratio, 3.82; 95% confidence interval, 2.09-6.97;

Indexed as

interictal epileptiform dischargeperiodic dischargepoststroke epilepsyseizure recurrence

Identifiers

PMID36523270
PMCPMC9746685
OpenAlexW4309977669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.